ES8503947A1 - Agentes antimicoticos con elevada liberacion del producto activo - Google Patents

Agentes antimicoticos con elevada liberacion del producto activo

Info

Publication number
ES8503947A1
ES8503947A1 ES530846A ES530846A ES8503947A1 ES 8503947 A1 ES8503947 A1 ES 8503947A1 ES 530846 A ES530846 A ES 530846A ES 530846 A ES530846 A ES 530846A ES 8503947 A1 ES8503947 A1 ES 8503947A1
Authority
ES
Spain
Prior art keywords
cream
active compounds
high release
antimycotic agent
antimycotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530846A
Other languages
English (en)
Other versions
ES530846A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES530846A0 publication Critical patent/ES530846A0/es
Publication of ES8503947A1 publication Critical patent/ES8503947A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PREPARADOS DE BIFONAZOL QUE LIBERA EL PRODUCTO ACTIVO.CONSISTE EN LA REACCION DEL CARBINOL DE FORMULA (I) CON TIONIL-BIS-IMIDAZOL, SEGUIDA DE LA EVENTUAL REACCION CON ACIDOS FISIOLOGICAMENTE ACEPTABLES, Y EL PRODUCTO PBTENIDO SE MEZCLA CON 5-25 DE AGENTES EXTENDEDORES Y CON PRODUCTOS USUALES DE FORMULACION Y DILUYENTES.ESTOS PREPARADOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO ANTIMICOTICO.
ES530846A 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo Expired ES8503947A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
ES530846A0 ES530846A0 (es) 1985-04-16
ES8503947A1 true ES8503947A1 (es) 1985-04-16

Family

ID=6195162

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530846A Expired ES8503947A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Expired ES8601693A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Expired ES8601693A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Country Status (19)

Country Link
JP (1) JPS59184106A (es)
KR (1) KR840008284A (es)
AU (1) AU564956B2 (es)
BE (1) BE899278A (es)
CA (1) CA1212327A (es)
CH (1) CH660126A5 (es)
CY (1) CY1358A (es)
DE (1) DE3311701A1 (es)
ES (3) ES8503947A1 (es)
FR (1) FR2543435B1 (es)
GB (1) GB2137091B (es)
GR (1) GR81485B (es)
IT (1) IT1173761B (es)
KE (1) KE3704A (es)
LU (1) LU85271A1 (es)
PH (1) PH20420A (es)
PT (1) PT78313B (es)
SE (1) SE8401748L (es)
ZA (1) ZA842337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
ES539290A0 (es) 1985-11-16
GB2137091A (en) 1984-10-03
ES8601693A1 (es) 1985-11-16
CH660126A5 (de) 1987-03-31
DE3311701A1 (de) 1984-10-04
AU2623684A (en) 1984-10-04
IT8420303A0 (it) 1984-03-29
SE8401748D0 (sv) 1984-03-29
FR2543435A1 (fr) 1984-10-05
ES8601692A1 (es) 1985-11-16
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
FR2543435B1 (fr) 1988-06-17
SE8401748L (sv) 1984-10-01
CA1212327A (en) 1986-10-07
ES539289A0 (es) 1985-11-16
PH20420A (en) 1987-01-05
KE3704A (en) 1987-03-27
GB2137091B (en) 1986-10-01
CY1358A (en) 1987-08-07
ES530846A0 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
AU564956B2 (en) 1987-09-03
BE899278A (fr) 1984-10-01
PT78313A (en) 1984-04-01
GB8408067D0 (en) 1984-05-10
GR81485B (es) 1984-12-11
IT1173761B (it) 1987-06-24
JPS59184106A (ja) 1984-10-19
KR840008284A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
ES8502334A1 (es) "un procedimiento para preparar una composicion que contiene elastasa".
GB8528201D0 (en) Margarine &c fat compositions
HUT46851A (en) Process for producing improves pharmaceutical compositions containing flunarazine
EP0133030A3 (en) Water-soluble coolant for formation of drawn and ironed cans
HK49792A (en) Hair rinse composition
JPS5640605A (en) Cosmetic
ES8601693A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
AU545531B2 (en) A non-toxic anthelmintic pour-on composition
JPS52806A (en) Preparation of ester
JPS5549313A (en) Vitamin pharmaceutical and its preparation
JPS5753401A (en) Hair nourishing agent for promoting hair growth
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
SE8301565L (sv) Oljeloslig komposition innehallande fettloslig vitamin
JPS5421979A (en) Composition for emulsifying agnet or sulubilizing agnet
KR840007522A (ko) 지방산 함유 양모제 조성물
JPS55133306A (en) Perfume controller
JPS56131344A (en) Preparation of foaming fat or oil for cake
JPS5751746A (en) Thermoplastic resin composition
JPS5672651A (en) Fats and oils for spray
JPS545948A (en) Cyclopropanecarboxylic acid esters, process for their prparation, and isecticide having low toxicity to fishees, containing the same as active constituents
JPS5594317A (en) Antifungal agent
JPS5531036A (en) Improved skin cream
JPS537627A (en) Optically active unsaturated esters and their preparation
JPS6411187A (en) Antioxidant
JPS5582186A (en) Antioxidant